Cerity Partners
LKFT icon

Cerity Partners’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Cerity Partners’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Sell
10,000
-310
-3% -$8.8K ﹤0.01% 2789
2026
Q1 		$309K Buy
+10,310
New +$341K ﹤0.01% 2590

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Cerity Partners's LKFT Position: Q2 2026 in Review

Cerity Partners reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 3% in Q2 2026, selling an estimated $8.8K and leaving 10,000 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #2789.

Cerity Partners first reported a position in LKFT in Q1 2026 and has held it in 2 quarters since. The position peaked at $309K in Q1 2026. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Cerity Partners held 10,000 shares of Lakefront Biotherapeutics American Depositary Shares worth $300K as of Q2 2026.
  • Cerity Partners sold 310 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $8.8K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2789 holding.
  • Cerity Partners first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2026 and has held it in 2 quarters since.
  • Cerity Partners's Lakefront Biotherapeutics American Depositary Shares position peaked at $309K in Q1 2026.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.